VSTM
Verastem, Inc.Company Information
- Company Name
- Verastem, Inc.
- CIK
- CIK0001526119
- Category
- Non-accelerated filer<br>Smaller reporting company
- Ticker: Exchange
- VSTM: Nasdaq
- Fiscal Year End
- December 31
- Owner Organization
- 03 Life Sciences
- SIC
- 2834
- SIC Description
- Pharmaceutical Preparations
- Ticker
- VSTM
SEC filing data through
Insider Sentiment
- Last purchase
- —
- Last sale
- 2026-09-21
- Shares purchased (TTM)
- 0
- Shares sold (TTM)
- 81,258
Institutional Sentiment
- As of
- 2026-06-30
- Institutional shares owned
- 94,900,012
- Shares outstanding
- 100,116,000
- Ownership
- 94.79%
Earnings Market Reaction
- Filing date
- 2026-08-06
- Price on filing date
- —
- 1-month reaction
- 22.17%
- 3-month reaction
- …
Balance Sheet
Values in millions ($)| Line item | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 | 2024-03-31 | 2023-12-31 | 2023-09-30 | Subscriber-only column | Subscriber-only column | Subscriber-only column | Subscriber-only column | Subscriber-only column | Trend |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Series B Convertible Preferred Stock | - | - | 0 | 0 | 0 | 0 | 1 | 1 | 1 | 10 | 1 | 1 | ||||||
Assets Current | ||||||||||||||||||
| Available For Sale Securities Debt Securities Current | - | - | - | - | - | - | - | - | - | 29 | 59 | 71 | ||||||
| Cash And Cash Equivalents At Carrying Value | 136 | 166 | 205 | 138 | 164 | 118 | 89 | 113 | 83 | 81 | 78 | 95 | ||||||
| Short Term Investments | - | 16 | - | - | - | - | - | - | - | - | - | - | ||||||
| Accounts Receivable Net | 29 | 10 | 9 | 7 | 2 | - | - | - | 10 | - | - | - | ||||||
| Inventory Net | 2 | 2 | 2 | 2 | 1 | - | - | - | - | - | - | - | ||||||
| Prepaid Expense And Other Assets Current | 8 | 9 | 8 | 8 | 7 | 7 | 6 | 7 | 5 | 7 | 7 | 9 | ||||||
| Assets Current | 176 | 203 | 223 | 154 | 174 | 125 | 95 | 121 | 100 | 118 | 144 | 174 | ||||||
| Property Plant And Equipment Net | - | - | - | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | ||||||
| Operating Lease Right Of Use Asset | 3 | 3 | 0 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | ||||||
| Restricted Cash And Cash Equivalents Noncurrent | 0 | 0 | - | - | - | 0 | 0 | - | 0 | 0 | 0 | 0 | ||||||
| Finite Lived Intangible Assets Net | 16 | 16 | 16 | 17 | 16 | - | - | - | - | - | - | - | ||||||
| Other Assets Noncurrent | 12 | 6 | 6 | 5 | 5 | 6 | 5 | 5 | 5 | 5 | 5 | 0 | ||||||
| Assets | 207 | 228 | 246 | 177 | 196 | 132 | 102 | 126 | 106 | 124 | 150 | 176 | ||||||
Liabilities Current | ||||||||||||||||||
| Accounts Payable Current | 18 | 10 | 12 | 10 | 8 | 7 | 4 | 4 | 7 | 7 | 7 | 5 | ||||||
| Accrued Liabilities Current | 54 | 51 | 54 | 45 | 38 | 25 | 26 | 22 | 17 | 17 | 18 | 16 | ||||||
| Deferred Revenue Current | - | - | - | - | - | - | - | - | - | - | 0 | - | ||||||
| Notes Payable Current | 0 | 1 | - | 0 | 0 | 1 | - | 0 | 1 | 1 | - | 0 | ||||||
| Supplier Finance Program Obligation Current | 5 | 5 | 5 | - | - | - | - | - | - | - | - | - | ||||||
| Operating Lease Liability Current | 0 | 0 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | ||||||
| Secured Debt Current | - | - | - | - | - | - | - | 10 | 5 | - | - | - | ||||||
| Liabilities Current | 78 | 67 | 72 | 60 | 50 | 36 | 31 | 37 | 30 | 27 | 26 | 24 | ||||||
Liabilities Noncurrent | ||||||||||||||||||
| Other Liabilities Noncurrent | - | - | - | - | - | - | - | - | - | - | - | 0 | ||||||
| Secured Long Term Debt | 74 | 73 | 76 | 78 | 74 | 71 | 41 | 31 | 35 | 40 | 40 | 40 | ||||||
| Supplier Finance Program Obligation Noncurrent | 3 | 4 | 5 | - | - | - | - | - | - | - | - | - | ||||||
| Warrants And Rights Outstanding | - | - | 36 | 48 | 22 | 55 | 58 | 26 | - | - | - | - | ||||||
| Operating Lease Liability Noncurrent | 2 | 2 | - | - | - | 0 | 1 | - | - | 0 | 1 | 1 | ||||||
| Liabilities | 157 | 146 | 189 | 192 | 160 | 164 | 130 | 94 | 66 | 77 | 71 | 72 | ||||||
| Convertible Preferred Stock Nonredeemable Or Redeemable Issuer Option Value | - | - | - | - | - | - | - | 21 | 21 | - | 21 | - | ||||||
Stockholders Equity | ||||||||||||||||||
| Accounts Payable And Accrued Liabilities Noncurrent | - | - | - | - | 8 | - | - | - | - | - | - | - | ||||||
Convertible Preferred Stock | ||||||||||||||||||
| Common Stock Value | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | ||||||
| Additional Paid In Capital Common Stock | 1,278 | 1,275 | 1,217 | 1,114 | 1,064 | 969 | 927 | 902 | 886 | 884 | 882 | 881 | ||||||
| Accumulated Other Comprehensive Income Loss Net Of Tax | 8 | 9 | 5 | 3 | 5 | 7 | - | - | - | -0 | 0 | 0 | ||||||
| Retained Earnings Accumulated Deficit | -1,236 | -1,202 | -1,165 | -1,132 | -1,034 | -1,008 | -956 | -891 | -867 | -859 | -825 | -798 | ||||||
| Stockholders Equity | 50 | 82 | 57 | -16 | 36 | -32 | -29 | 11 | 19 | 25 | 57 | 83 | ||||||
| Liabilities And Stockholders Equity | 207 | 228 | 246 | 177 | 196 | 132 | 102 | 126 | 106 | 124 | 150 | 176 | ||||||
| Series A Preferred Stock | - | - | - | - | - | - | - | - | 1 | 1 | 1 | 0 | ||||||
| Series B Preferred Stock | - | - | - | - | - | - | - | - | 1 | 1 | 1 | - | ||||||
| Seriesa Convertible Preferred Stock | - | - | 0 | 0 | -1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | ||||||
| Preferred Stock | - | - | 0 | - | - | - | 1 | - | - | - | 4 | - | ||||||
| Preferred Stock Par Or Stated Value Per Share | 0.00 | 0.00 | - | 0.00 | 0.00 | 0.00 | - | 0.00 | - | - | - | - | ||||||
| Preferred Stock Shares Authorized | 5 | 5 | 5 | 5 | 5 | 5 | 5 | 5 | 5 | 5 | 5 | 5 | ||||||
| Preferred Stock Shares Issued | 0 | 0 | - | - | - | - | - | - | - | - | - | - | ||||||
| Preferred Stock Shares Outstanding | 0 | 0 | - | - | - | - | - | - | - | - | - | 1 | ||||||
| Common Stock Par Or Stated Value Per Share | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | ||||||
| Common Stock Shares Authorized | 300 | 300 | 300 | 300 | 300 | 300 | 300 | 300 | 300 | 300 | 300 | 300 | ||||||
| Common Stock Shares Issued | 90 | 88 | 78 | 67 | 62 | 51 | 45 | 40 | 27 | 25 | 25 | 25 | ||||||
| Shares Outstanding | 90 | 88 | 78 | 67 | 62 | 51 | 45 | 40 | 27 | 25 | 25 | 25 | ||||||
Select a line item above to chart it.
Recent filings
- 10-QFiled
- 10-QFiled
- 10-KFiled
- 10-QFiled
- 10-QFiled
- 10-QFiled
- 10-KFiled
- 10-QFiled
- 10-QFiled
- 10-QFiled
- 10-KFiled
- 10-QFiled
Financial statements beyond 3 years are for subscribers only.
Unlock 17+ years of income statements, balance sheets, and cash flow statements
Start 7-day free trialVerastem, Inc. (VSTM) — SEC Financial Statements & Analysis
Verastem, Inc. (VSTM) is a pharmaceutical preparations company, incorporated in MA. Verastem, Inc. trades on Nasdaq as: VSTM. Verastem, Inc. (VSTM)'s most recent SEC filing is a Form 10-Q for the period ended 2026-06-30, filed with the SEC on 2026-08-06. Based on that filing, Verastem, Inc. carries a market cap of $382.44M, a P/E ratio of -1.89x, a P/B ratio of 7.65x, a P/S ratio of 4.77x, an enterprise value of $319.84M, and an EV/EBITDA multiple of -2.01x. On profitability, it posts a gross margin of 101.84%, an operating margin of -199.51%, a net margin of -253.07%, a Return on Equity (ROE) of -471.16%, a Return on Assets (ROA) of -100.65%, and a Return on Invested Capital (ROIC) of -1241.11%. Per share, it reports EPS of $-2.02, diluted EPS of $-2.02, free cash flow per share of $-1.72, and a dividend per share of $0.00. Over the trailing year, it posted revenue growth of -979.70% year-over-year, net income growth of 21.70% year-over-year, and EPS growth of -19.60% year-over-year. On the balance sheet, it maintains a current ratio of 2.25x, a quick ratio of 2.12x, working capital of $98.03M, a debt-to-equity ratio of 3.13x, a debt ratio of 0.76, an interest coverage ratio of -108.26x, free cash flow of $-171.82M (TTM), and net debt of $-62.61M. Figures sourced from SEC EDGAR.
- Market Cap
- $382.44M
- P/E TTM
- -1.89x
- EPS TTM
- $-2.02
- P/B TTM
- 7.65x
- ROE TTM
- -471.16%
- ROA TTM
- -100.65%
- Debt To Equity
- 3.13x
- Free Cash Flow TTM
- $-171.82M
- Net Revenue TTM Growth 1Y
- -979.70%
Data as of 2026-06-30 · Source: SEC EDGAR
Frequently Asked Questions
What industry is Verastem, Inc. in?
Verastem, Inc. (VSTM) operates in the Pharmaceutical Preparations industry.
What exchange does VSTM trade on?
Verastem, Inc. (VSTM) trades on the Nasdaq.
Where is Verastem, Inc. incorporated?
Verastem, Inc. is incorporated in MA.
When was Verastem, Inc. (VSTM)'s most recent SEC filing?
Verastem, Inc. (VSTM)'s most recent SEC filing is a Form 10-Q for the period ended 2026-06-30, filed with the SEC on 2026-08-06.
What is VSTM's market cap?
Verastem, Inc. (VSTM) has a market capitalization of $382.44M as of 2026-06-30.
What is VSTM's EPS (earnings per share)?
Verastem, Inc. (VSTM)'s trailing twelve month EPS is $-2.02 as of 2026-06-30.
What is VSTM's ROE (return on equity)?
Verastem, Inc. (VSTM)'s trailing twelve month Return on Equity (ROE) is -471.16% as of 2026-06-30.
What is VSTM's ROA (return on assets)?
Verastem, Inc. (VSTM)'s trailing twelve month Return on Assets (ROA) is -100.65% as of 2026-06-30.
What is VSTM's ROIC (return on invested capital)?
Verastem, Inc. (VSTM)'s trailing twelve month Return on Invested Capital (ROIC) is -1241.11% as of 2023-12-31.
What is VSTM's EV/EBITDA?
Verastem, Inc. (VSTM)'s trailing twelve month EV/EBITDA is -2.01x as of 2026-06-30.